Despite a decrease in IABP use for cardiogenic shock during PCI, there has been no compensatory increase in other mechanical circulatory support devices, which remain concentrated in a few hospitals.
In this large national registry, the use of IABP in the setting of PCI for cardiogenic shock decreased over time without a concurrent increase in O-MCS use. The probability of IABP and O-MCS use varied across hospitals, and the use of O-MCS was clustered at a small number of hospitals.
Sandhu et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: